SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-16-118750
Filing Date
2016-05-06
Accepted
2016-05-06 16:05:56
Documents
4
Effectiveness Date
2016-05-06

Document Format Files

Seq Description Document Type Size
1 S-8 a16-10602_1s8.htm S-8 122135
2 EX-5.1 a16-10602_1ex5d1.htm EX-5.1 11302
3 EX-23.2 a16-10602_1ex23d2.htm EX-23.2 3639
4 GRAPHIC g106021kei001.jpg GRAPHIC 4342
  Complete submission text file 0001104659-16-118750.txt   144298
Mailing Address 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301
Business Address 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301 720-945-7700
Nivalis Therapeutics, Inc. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-211197 | Film No.: 161627992
SIC: 2834 Pharmaceutical Preparations